Diagnostic Performance of ACR-TIRADS in Differentiating Benign From Malignant Thyroid Nodules in Patients Undergoing Fine-Needle Aspiration Biopsy: Comparative Study Based on Five International Guidelines for Management of Thyroid Nodules
Journal of Endocrinology and Metabolism · 2021-08 · 11 (3-4) · 69-75
DOI: 10.14740/jem735 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Endocrinology and Metabolism, 2021-08. Verfasst von Pranav Sharma und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sharma, P., Elfatairy, K., Gandhi, D., Sawhney, H., Osman, M., Kochar, P. S., & Cohen, S. (2021). Diagnostic Performance of ACR-TIRADS in Differentiating Benign From Malignant Thyroid Nodules in Patients Undergoing Fine-Needle Aspiration Biopsy: Comparative Study Based on Five International Guidelines for Management of Thyroid Nodules. Journal of Endocrinology and Metabolism, 11(3-4), 69-75. https://doi.org/10.14740/jem735
Vancouver
Sharma P, Elfatairy K, Gandhi D, Sawhney H, Osman M, Kochar PS, et al. Diagnostic Performance of ACR-TIRADS in Differentiating Benign From Malignant Thyroid Nodules in Patients Undergoing Fine-Needle Aspiration Biopsy: Comparative Study Based on Five International Guidelines for Management of Thyroid Nodules. Journal of Endocrinology and Metabolism. 2021;11(3-4):69-75. doi:10.14740/jem735
BibTeX
@article{Sharma2021,
author = {Sharma, Pranav and Elfatairy, Kareem and Gandhi, Darshan and Sawhney, Harpreet and Osman, Mohammed and Kochar, Puneet S. and Cohen, Steven},
title = {Diagnostic Performance of ACR-TIRADS in Differentiating Benign From Malignant Thyroid Nodules in Patients Undergoing Fine-Needle Aspiration Biopsy: Comparative Study Based on Five International Guidelines for Management of Thyroid Nodules},
journal = {Journal of Endocrinology and Metabolism},
year = {2021},
volume = {11},
number = {3-4},
pages = {69--75},
doi = {10.14740/jem735}
}
EUVIMED